ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $812,056 | +194.0% | 176,534 | +312.8% | 0.00% | – |
| Q2 2023 | $276,248 | -77.8% | 42,763 | -74.1% | 0.00% | – |
| Q1 2023 | $1,246,822 | +26.3% | 165,361 | +69.7% | 0.00% | – |
| Q4 2022 | $986,955 | +30.5% | 97,429 | +27.6% | 0.00% | – |
| Q3 2022 | $756,000 | +59.8% | 76,362 | +72.1% | 0.00% | – |
| Q2 2022 | $473,000 | +318.6% | 44,378 | +281.1% | 0.00% | – |
| Q1 2022 | $113,000 | +91.5% | 11,644 | +183.4% | 0.00% | – |
| Q4 2021 | $59,000 | +20.4% | 4,108 | +67.9% | 0.00% | – |
| Q3 2021 | $49,000 | -98.7% | 2,447 | -98.6% | 0.00% | – |
| Q2 2021 | $3,758,000 | – | 170,816 | +17081500.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |